- Poster Presentation
- Open Access
The NEUREGULIN1gene and breast cancer
Breast Cancer Research volume 8, Article number: P5 (2006)
It has long been suspected that there is a tumour suppressor gene on chromosome 8p, and our array CGH data  suggest that it may be close to the WRN and NEUREGULIN1 (NRG1) genes. NRG1 encodes growth factors that function as ligands for the tyrosine kinases ErbB3 and ErbB4, and can both stimulate cell proliferation, differentiation and apoptosis. We previously showed that many breast carcinoma (that is, 39% of cancer cell lines and 6% of breast tumours) have chromosome breakpoints in NRG1, suggesting that the gene plays an important role in tumourigenesis [2, 3], and our initial hypothesis was that the translocations activate expression.
Our current work shows that NRG1 expression is silenced in many breast cancer cell lines (17 out of 23 lines), as compared with normal breast cell lines. Western blotting experiments also indicate that NRG1 is downregulated at the protein level. To investigate whether NRG1 maybe repressed by epigenetic mechanisms, we examined DNA methylation at a CpG island present in the promoter and the first exon of the gene using bisulphite sequencing. This region is heavily methylated in 76.5% (13/17) of breast cancer cell lines that have no NRG1 expression. In contrast, the region is relatively unmethylated in normal breast lines, and in cancer cell lines expressing NRG1. Treatment of cancer cell lines with 5-aza-2-deoxycytidine, which abolished DNA methylation, activated the expression of NRG1 by 7–100 times.
These results suggest that DNA methylation is a key mechanism that silences NRG1 expression in breast cancer cells, and our current view is that NRG1 could be the long-sought tumour suppressor on 8p, with the translocations either inactivating the gene or producing aberrant transcripts.
Pole JC, Courtay-Cahen C, Garcia MJ, Blood KA, Cooke SL, Alsop AE, Tse DM, Caldas C, Edwards PA: High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation. Oncogene. 2006
Adelaide J, Huang HE, Murati A, Alsop AE, Orsetti B, Mozziconacci MJ, Popovici C, Ginestier C, Letessier A, Basset C, et al: A recurrent chromosome translocation breakpoint in breast and cancer cell lines targets the neuregulin/NRG1 gene. Genes Chromosome Cancer. 2003, 37: 333-345. 10.1002/gcc.10218.
Huang HE, Chin SF, Ginestier C, Bardou VJ, Adelaide J, Iyer NG, Garcia MJ, Pole JC, Callagy GM, Hewitt SM, et al: A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene. Cancer Res. 2006, 64: 6840-6844. 10.1158/0008-5472.CAN-04-1762.
The authors thank Breast Cancer Campaign for funding.
About this article
Cite this article
Chua, Y., Edwards, P. The NEUREGULIN1gene and breast cancer. Breast Cancer Res 8, P5 (2006). https://doi.org/10.1186/bcr1560
- Breast Cancer Cell Line
- Normal Breast
- Western Blotting Experiment
- Breast Cell Line